×
About 4,773 results

ALLMedicine™ Glucose Intolerance Center

Research & Reviews  1,717 results

Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation d...
https://doi.org/10.1007/s12020-021-02834-7 10.1053/j.gastro.2020.01.052 10.1152/ajpgi.00426.2010 10.1161/CIRCULATIONAHA.105.169404 10.1016/j.mce.2012.04.013 10.1016/j.jhep.2008.03.018 10.1016/j.mce.2008.12.011 10.1161/hy1101.092970 10.1016/j.metabol.2005.06.016 10.1152/ajpendo.00199.2004 10.1152/ajpendo.00090.2004 10.1080/08998280.2003.11927893 10.2174/157016111794519318 10.18632/oncotarget.23816 10.1038/s41440-018-0040-6 10.1177/147323000102900402 10.1038/hr.2013.3 10.1210/en.2012-1390 10.1152/ajpgi.00365.2010 10.1073/pnas.95.15.8625 10.3350/cmh.2013.19.3.210 10.1186/s12944-018-0790-9 10.1152/ajpendo.00226.2010 10.1053/j.gastro.2006.02.006 10.1007/s00018-018-2860-6 10.1016/j.bbrc.2005.08.070 10.1136/gut.2010.222844 10.1089/ars.2018.7544 10.1089/ars.2010.3412 10.1152/ajpgi.90583.2008 10.1016/j.biocel.2017.12.019 10.1152/ajpendo.00192.2014 10.1586/egh.09.32 10.1016/j.freeradbiomed.2018.10.405 10.3390/nu10101502 10.1038/hr.2011.222 10.1159/000453037 10.1038/hr.2011.206 10.1007/s11906-011-0205-z 10.1016/0168-8227(94)90269-0 10.2337/diab.41.11.1422 10.2147/vhrm.2006.2.4.327 10.5812/ijem.3505 10.1152/ajpendo.00610.2012 10.1198/sbr.2009.0025 10.1152/ajpendo.00042.2020 10.4097/kjae.2017.70.4.407 10.1111/bph.12510 10.1186/1475-2840-6-26 10.1097/MD.0000000000020674 10.1291/hypres.31.921 10.1038/hr.2010.99 10.1016/j.aohep.2020.08.070 10.1111/hepr.12710 10.1016/j.ijcard.2012.02.008 10.1155/2013/342648 10.1016/j.ramb.2013.05.003 10.1016/j.jhep.2009.01.018 10.1146/annurev-nutr-071812-161220 10.1016/j.mam.2012.07.010 10.1007/s00535-019-01633-2 10.1172/jci.insight.93626 10.1073/pnas.0404297101 10.1016/j.redox.2017.10.005 10.1038/s41387-018-0045-x 10.1194/jlr.R800018-JLR200 10.3390/children4060046 10.1016/j.tem.2011.04.007 10.1155/2019/9685607 10.1152/ajpendo.00193.2019 10.1681/ASN.2004080649 10.1172/JCI118173 10.1038/89969 10.1074/jbc.M803510200 10.1042/bj3200345 10.1016/S0163-7827(03)00051-1 10.1194/jlr.R800053-JLR200 10.1002/hep.27695 10.1002/hep.22980 10.1038/75651 10.1101/gad.12.20.3182 10.1073/pnas.1808968115 10.1053/j.gastro.2007.11.038 10.1172/JCI6246 10.1089/ars.2012.4946 10.1002/pmic.200300810 10.1089/ars.2010.3766
Endocrine Godoy-Lugo JA, Thorwald MA et. al.

Jul 31st, 2021 - Angiotensin receptor blockers (ARBs) can ameliorate metabolic syndrome (MetS)-associated dyslipidemia, hepatic steatosis, and glucose intolerance, suggesting that angiotensin receptor (AT1) over-activation contributes to impaired lipid and glucose...

Transplantation of an obesity-associated human gut microbiota to mice induces vascular ...
https://doi.org/10.1080/19490976.2021.1940791
Gut Microbes; Trikha SRJ, Lee DM et. al.

Jul 28th, 2021 - Recent preclinical data suggest that alterations in the gut microbiota may be an important factor linking obesity to vascular dysfunction, an early sign of cardiovascular disease. The purpose of this study was to begin translation of these preclin...

Association of leukocyte counts in the first trimester with glucose intolerance during ...
https://doi.org/10.1111/jdi.13633
Journal of Diabetes Investigation; Wang L, Li W et. al.

Jul 22nd, 2021 - We investigated the association between leukocyte counts and glucose challenge test (GCT) level during pregnancy. we collected prenatal information of women who had their first clinic visit in early pregnancy. Women underwent GCT at 24 to 28 gesta...

Antiobesity, hepatoprotective and anti-hyperglycemic effects of a pharmaceutical formul...
https://doi.org/10.1016/j.jep.2021.114418
Journal of Ethnopharmacology; Campos ML, Castro MB et. al.

Jul 17th, 2021 - The leaves of Cecropia pachystachya Trécul (Urticaceae), known as embaúba, are used as hypoglycemic and for weight reduction in Brazilian traditional medicine. This study investigated the effects of a pharmaceutical formulation (ECP20) containing ...

see more →

Guidelines  2 results

The polycystic ovary syndrome: a position statement from the European Society of Endocr...
https://doi.org/10.1530/EJE-14-0253
European Journal of Endocrinology; Conway G, Dewailly D et. al.

May 23rd, 2014 - Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The...

Consensus on infertility treatment related to polycystic ovary syndrome.
https://doi.org/10.1016/j.fertnstert.2007.09.041
Fertility and Sterility;

Feb 5th, 2008 - The treatment of infertile women with polycystic ovary syndrome (PCOS) is surrounded by many controversies. On the basis of the currently available evidence, a group of experts reached a consensus regarding the therapeutic challenges raised in the...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  100 results

Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance
https://clinicaltrials.gov/ct2/show/NCT00085982

May 5th, 2020 - Since this protocol was initiated, we have observed that recombinant leptin has improved metabolic abnormalities in subjects with lipoatrophy and leptin deficiency . The mechanism by which leptin treatment improves insulin sensitivity in lipodystr...

Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome
https://clinicaltrials.gov/ct2/show/NCT03214068

May 5th, 2020 - The metabolic syndrome (MetS) is a clustering of multiple risk factors for atherosclerotic cardiovascular disease such as central obesity, impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM), elevated triglyceride (TG), reduced high ...

Microbiome and Non-caloric Sweeteners in Humans
https://clinicaltrials.gov/ct2/show/NCT03708939

May 5th, 2020 - Non-caloric sweeteners are common food supplements consumed by millions worldwide as means of combating weight gain and diabetes, by retaining sweet taste without increasing caloric intake. While they are considered safe, there is increasing debat...

C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
https://clinicaltrials.gov/ct2/show/NCT00589355

Apr 17th, 2020 - The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to n...

Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption
https://clinicaltrials.gov/ct2/show/NCT02520258

Apr 13th, 2020 - Experiments have shown that some artificial sweeteners like those in diet soda can cause changes in how the body responds to and uses sugar. These changes increase the chance of obesity, type 2 diabetes mellitus, and other metabolic diseases. In t...

see more →

News  88 results

Brief High-Dose Saccharin Seems Safe, but Jury Out on Long-Term Use
https://www.medscape.com/viewarticle/944920

Jan 29th, 2021 - Consuming the maximum acceptable daily intake of the noncaloric artificial sweetener saccharin for 2 weeks did not alter gut microbiota diversity or composition, or induce glucose intolerance, in 23 healthy young men and women. And consuming four ...

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline
https://www.staging.medscape.com/viewarticle/940527

Nov 6th, 2020 - Vascular comorbidities, including diabetes and hypertension, are linked to significantly lower measures of neurologic function in people with multiple sclerosis (MS) vs patients without these comorbidities, new research shows. The research also sh...

Late Dinner Affects Metabolism, May Lead to Weight Gain, Diabetes
https://www.medscape.com/viewarticle/932395

Jun 16th, 2020 - Eating a late dinner alters metabolic markers during sleep in a way that could lead to obesity or diabetes, according to the results of a small randomized crossover clinical trial, the Effect of Late Dinner on Nocturnal Metabolism. Specifically, 2...

Late Dinner Affects Metabolism, May Lead to Weight Gain, Diabetes
https://www.staging.medscape.com/viewarticle/932395

Jun 16th, 2020 - Eating a late dinner alters metabolic markers during sleep in a way that could lead to obesity or diabetes, according to the results of a small randomized crossover clinical trial, the Effect of Late Dinner on Nocturnal Metabolism. Specifically, 2...

Polymyalgia Rheumatica Clinical Practice Guidelines (SIR, 2020)
https://reference.medscape.com/viewarticle/930126

May 11th, 2020 - In April 2020, the Italian Society of Rheumatology published their recommendations for the management of patients with a diagnosis of polymyalgia rheumatica.[1] Pretreatment Evaluation All patients with clinically diagnosed polymyalgia rheumatica ...

see more →